542 related articles for article (PubMed ID: 31173859)
1. Challenges of gene delivery to the central nervous system and the growing use of biomaterial vectors.
Puhl DL; D'Amato AR; Gilbert RJ
Brain Res Bull; 2019 Aug; 150():216-230. PubMed ID: 31173859
[TBL] [Abstract][Full Text] [Related]
2. Liposomal and viral vectors for gene therapy of the central nervous system.
de Lima MC; da Cruz MT; Cardoso AL; Simoes S; de Almeida LP
Curr Drug Targets CNS Neurol Disord; 2005 Aug; 4(4):453-65. PubMed ID: 16101560
[TBL] [Abstract][Full Text] [Related]
3. Gene delivery with viral vectors for cerebrovascular diseases.
Gan Y; Jing Z; Stetler RA; Cao G
Front Biosci (Elite Ed); 2013 Jan; 5(1):188-203. PubMed ID: 23276981
[TBL] [Abstract][Full Text] [Related]
4. Viral vectors for gene delivery to the central nervous system.
Lentz TB; Gray SJ; Samulski RJ
Neurobiol Dis; 2012 Nov; 48(2):179-88. PubMed ID: 22001604
[TBL] [Abstract][Full Text] [Related]
5. Cellular and molecular neurosurgery: pathways from concept to reality--part II: vector systems and delivery methodologies for gene therapy of the central nervous system.
Zlokovic BV; Apuzzo ML
Neurosurgery; 1997 Apr; 40(4):805-12; discussion 812-3. PubMed ID: 9092854
[TBL] [Abstract][Full Text] [Related]
6. Non-viral nucleic acid delivery to the central nervous system and brain tumors.
Wang S; Huang R
J Gene Med; 2019 Jul; 21(7):e3091. PubMed ID: 30980444
[TBL] [Abstract][Full Text] [Related]
7. Current status of non-viral gene therapy for CNS disorders.
Jayant RD; Sosa D; Kaushik A; Atluri V; Vashist A; Tomitaka A; Nair M
Expert Opin Drug Deliv; 2016 Oct; 13(10):1433-45. PubMed ID: 27249310
[TBL] [Abstract][Full Text] [Related]
8. Invasive drug delivery.
Blömer U; Ganser A; Scherr M
Adv Exp Med Biol; 2002; 513():431-51. PubMed ID: 12575831
[TBL] [Abstract][Full Text] [Related]
9. Gene therapy and neurodevelopmental disorders.
Gray SJ
Neuropharmacology; 2013 May; 68():136-42. PubMed ID: 22750077
[TBL] [Abstract][Full Text] [Related]
10. Adeno-associated virus vectors and neurological gene therapy.
Ojala DS; Amara DP; Schaffer DV
Neuroscientist; 2015 Feb; 21(1):84-98. PubMed ID: 24557878
[TBL] [Abstract][Full Text] [Related]
11. Viral vectors and delivery strategies for CNS gene therapy.
Gray SJ; Woodard KT; Samulski RJ
Ther Deliv; 2010 Oct; 1(4):517-34. PubMed ID: 22833965
[TBL] [Abstract][Full Text] [Related]
12. The Challenge of Gene Therapy for Neurological Diseases: Strategies and Tools to Achieve Efficient Delivery to the Central Nervous System.
Piguet F; de Saint Denis T; Audouard E; Beccaria K; André A; Wurtz G; Schatz R; Alves S; Sevin C; Zerah M; Cartier N
Hum Gene Ther; 2021 Apr; 32(7-8):349-374. PubMed ID: 33167739
[TBL] [Abstract][Full Text] [Related]
13. Defective viral vectors as agents for gene transfer in the nervous system.
Kaplitt MG; Makimura H
J Neurosci Methods; 1997 Jan; 71(1):125-32. PubMed ID: 9125381
[TBL] [Abstract][Full Text] [Related]
14. Adeno-associated viral vectors as agents for gene delivery: application in disorders and trauma of the central nervous system.
Ruitenberg MJ; Eggers R; Boer GJ; Verhaagen J
Methods; 2002 Oct; 28(2):182-94. PubMed ID: 12413416
[TBL] [Abstract][Full Text] [Related]
15. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications.
Wong LF; Goodhead L; Prat C; Mitrophanous KA; Kingsman SM; Mazarakis ND
Hum Gene Ther; 2006 Jan; 17(1):1-9. PubMed ID: 16409120
[TBL] [Abstract][Full Text] [Related]
16. Non-viral nanosystems for gene and small interfering RNA delivery to the central nervous system: formulating the solution.
O'Mahony AM; Godinho BM; Cryan JF; O'Driscoll CM
J Pharm Sci; 2013 Oct; 102(10):3469-84. PubMed ID: 23893329
[TBL] [Abstract][Full Text] [Related]
17. Clinical gene therapy development for the central nervous system: Candidates and challenges for AAVs.
Leong TW; Pal A; Cai Q; Gao Z; Li X; Bleris L; Hayenga HN; Qin Z
J Control Release; 2023 May; 357():511-530. PubMed ID: 37040842
[TBL] [Abstract][Full Text] [Related]
18. Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.
Joshi CR; Labhasetwar V; Ghorpade A
J Neuroimmune Pharmacol; 2017 Mar; 12(1):51-83. PubMed ID: 28160121
[TBL] [Abstract][Full Text] [Related]
19. Is Viral Vector Gene Delivery More Effective Using Biomaterials?
Wang Y; Bruggeman KF; Franks S; Gautam V; Hodgetts SI; Harvey AR; Williams RJ; Nisbet DR
Adv Healthc Mater; 2021 Jan; 10(1):e2001238. PubMed ID: 33191667
[TBL] [Abstract][Full Text] [Related]
20. Methods for gene transfer to the central nervous system.
Kantor B; Bailey RM; Wimberly K; Kalburgi SN; Gray SJ
Adv Genet; 2014; 87():125-97. PubMed ID: 25311922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
